Levalox

Levofloxacin, the active ingredient in Levalox, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It is indicated for the treatment of serious bacterial infections, including community‑acquired respiratory tract infections, complicated urinary tract infections, skin and soft‑tissue infections, intra‑abdominal infections, and other severe infections that require IV therapy in adult patients.\n\nGNH India supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levalox (levofloxacin) is used to treat bacterial infections across several organ systems.\n\nCommunity‑acquired respiratory tract infections: eradicates susceptible pathogens and improves respiratory symptoms.\nComplicated urinary tract infections: clears infection and restores urinary function.\nSkin and soft‑tissue infections: eliminates causative bacteria and promotes wound healing.\nIntra‑abdominal infections: provides broad‑spectrum coverage for mixed flora.\nSevere bacterial infections requiring IV therapy: offers rapid systemic exposure for critically ill patients.

Levalox may cause a variety of adverse reactions, ranging from mild to severe.\n\nCommon Side Effects:\n- Nausea or vomiting\n- Diarrhea or abdominal discomfort\n- Headache or dizziness\n- Rash or mild skin irritation\n- Elevated liver enzymes\n- Transient increase in serum creatinine\n\nSerious or Rare Side Effects:\n- Tendon rupture or tendinitis, especially Achilles tendon\n- QT interval prolongation leading to arrhythmias\n- Severe hypersensitivity reactions including Stevens‑Johnson syndrome\n- Clostridioides difficile‑associated colitis\n- Peripheral neuropathy\n- Anaphylaxis or life‑threatening allergic response

Before initiating therapy with Levalox, clinicians should consider several safety measures.\n\nAssess renal function: adjust dose in patients with impaired clearance.\nReview allergy history: avoid in individuals with known fluoroquinolone hypersensitivity.\nMonitor for tendon pain: discontinue if signs of tendon inflammation appear.\nAvoid use in patients with known QT prolongation or concurrent QT‑prolonging drugs.\nUse with caution in pregnancy and breastfeeding: safety data are limited.\nStore at ambient temperature: keep in original container, protect from moisture and light.

Levalox can interact with other medicines, requiring careful management.\n\nMajor Interactions (Avoid):\n- Antacids, sucralfate, iron or zinc supplements: chelate the drug and reduce absorption.\n- Warfarin: may increase anticoagulant effect and bleeding risk.\n- Theophylline: can raise serum theophylline concentrations, leading to toxicity.\n\nModerate Interactions (Monitor Closely):\n- Corticosteroids: combined use may increase risk of tendon rupture.\n- Diabetes agents (e.g., insulin, sulfonylureas): may cause hypoglycemia.\n- Other QT‑prolonging agents: monitor cardiac rhythm for additive effects.